Predicting the Benefit of Statins in Patients With Diabetes Mellitus A Case of Perfect Being the Enemy of Good?

被引：1

作者：

Arnold, Suzanne V.

Kosiborod, Mikhail

机构：

[1] St Lukes Mid Amer Heart Inst, Dept Med, Kansas City, MO 64111 USA

[2] Univ Missouri, Kansas City, KS USA

来源：

CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES | 2016年 / 9卷 / 03期

关键词：

Editorials; decision making; diabetes mellitus; population groups; risk assessment; ACUTE MYOCARDIAL-INFARCTION; LIPID-LOWERING MEDICATIONS; NATIONAL REGISTRY; PREVENTION; OUTCOMES; ASPIRIN; DISEASE;

D O I：

10.1161/CIRCOUTCOMES.116.002859

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

引用

页码：191 / 193

页数：3

共 15 条

[1]

Quality improvement efforts and hospital performance - Rates of beta-blocker prescription after acute myocardial infarction [J].

Bradley, EH ;

Herrin, J ;

Mattera, JA ;

Holmboe, ES ;

Wang, YF ;

Frederick, P ;

Roumanis, SA ;

Radford, MJ ;

Krumholz, HM .

MEDICAL CARE, 2005, 43 (03) :282-292

[2]

Is diabetes a coronary risk equivalent? Systematic review and meta-analysis [J].

Bulugahapitiya, U. ;

Siyambalapitiya, S. ;

Sithole, J. ;

Idris, I. .

DIABETIC MEDICINE, 2009, 26 (02) :142-148

[3]

Evaluating prediction models in reproductive medicine [J].

Coppus, S. F. P. J. ;

van der Veen, F. ;

Opmeer, B. C. ;

Mol, B. W. J. ;

Bossuyt, P. M. M. .

HUMAN REPRODUCTION, 2009, 24 (08) :1774-1778

[4]

Adrenergic-Pathway Gene Variants Influence Beta-Blocker-Related Outcomes After Acute Coronary Syndrome in a Race-Specific Manner [J].

Cresci, Sharon ;

Dorn, Gerald W., II ;

Jones, Philip G. ;

Beitelshees, Amber L. ;

Li, Allie Y. ;

Lenzini, Petra A. ;

Province, Michael A. ;

Spertus, John A. ;

Lanfear, David E. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (10) :898-907

[5]

Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European carotid surgery trial (ECST) [J].

Farrell, B ;

Fraser, A ;

Sandercock, P ;

Slattery, J ;

Warlow, CP .

LANCET, 1998, 351 (9113) :1379-1387

[6]

Fonarow GC, 2001, CIRCULATION, V103, P38

[7]

Associations of diabetes mellitus with total life expectancy and life expectancy with and without cardiovascular disease [J].

Franco, Oscar H. ;

Steyerberg, Ewout W. ;

Hu, Frank B. ;

Mackenbach, Johan ;

Nusselder, Wilma .

ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (11) :1145-1151

[8]

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction [J].

Haffner, SM ;

Lehto, S ;

Rönnemaa, T ;

Pyörälä, K ;

Laakso, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (04) :229-234

[9]

Development and Validation of a Model to Predict Absolute Vascular Risk Reduction by Moderate-Intensity Statin Therapy in Individual Patients With Type 2 Diabetes Mellitus The Anglo Scandinavian Cardiac Outcomes Trial, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial, and Collaborative Atorvastatin Diabetes Study [J].

Kaasenbrood, Lotte ;

Poulter, Neil R. ;

Sever, Peter S. ;

Colhoun, Helen M. ;

Livingstone, Shona J. ;

Boekholdt, S. Matthijs ;

Pressel, Sara L. ;

Davis, Barry R. ;

van der Graaf, Yolanda ;

Visseren, Frank L. J. .

CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2016, 9 (03) :213-+

[10]

Aspirin for secondary prevention after acute myocardial infarction in the elderly: Prescribed use and outcomes [J].

Krumholz, HM ;

Radford, MJ ;

Ellerbeck, EF ;

Hennen, J ;

Meehan, TP ;

Petrillo, M ;

Wang, Y ;

Jencks, SF .

ANNALS OF INTERNAL MEDICINE, 1996, 124 (03) :292-+

← 1 2 →